Bids for bankrupt artificial blood-maker needed by Aug. 13
Bankrupt Biopure Corp. received court approval for an Aug. 20 asset sale, according to court and securities documents filed in recent days.
Potential bidders have until Aug. 13 to submit offers for the Cambridge-based blood substitute maker, which sought Chapter 11 bankruptcy protection July 17. The sealed bids will be opened Aug. 18, with the court expected to give its final approval to the deal two days later.
Over 25 years experience assisting a wide range of clients in their marketing communications needs. Sub-specialty in cGMP printing/packaging solutions for Life Science companies.
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.